Observational: Descriptive data will be collected to evaluation compliance with the protocol and to evaluate outcome
Study summary
The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data.
Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.
Eligibility
Sex
ALL
Min age
0 Months
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria:
under 18 years of age at diagnosis
* suffering from "classical" Hodgkin's disease according to the WHO classification.
* with no history of hematological malignancies or constitutional or acquired immune deficiencies
Exclusion Criteria:
* Over 18 years of age at diagnosis
* A history of hematological malignancies or a history of constitutional or a history of acquired immune deficiencies
Primary outcome measure(s)
Patient status — 24 months Dead or Alive
Drugs — 24 months The evaluation of the number of children who remain untreated because of lack of acess to chemotherapy
Trial sites (1)
Facility
City
Region
Status
Brenda Mallon
Paris
France
Recruiting
More French Africa Pediatric Oncology Group trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
